butylhydroxybutylnitrosamine has been researched along with Disease Models, Animal in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (17.07) | 18.7374 |
1990's | 7 (17.07) | 18.2507 |
2000's | 8 (19.51) | 29.6817 |
2010's | 16 (39.02) | 24.3611 |
2020's | 3 (7.32) | 2.80 |
Authors | Studies |
---|---|
Ando, R; Etani, T; Iida, K; Kato, H; Kawai, N; Nagai, T; Nagayasu, Y; Naiki, T; Naiki-Ito, A; Nozaki, S; Suzuki, S; Takahashi, S; Yasui, T | 1 |
Bonnal, JL; Mauroy, B; Philyppov, IB; Prevarskaya, N; Rock, A; Roudbaraki, M; Shuba, YM; Sotkis, GV | 1 |
Chourlia, A; Doroszko, M; Dragomir, A; Elgendy, R; Kerzeli, IK; Larsson, E; Lord, M; Malmstrom, PU; Mangsbo, SM; Nelander, S; Segersten, U; Stepanek, I; van Hooren, L | 1 |
Arantes-Rodrigues, R; Gil da Costa, RM; Oliveira, PA; Vasconcelos-Nóbrega, C | 1 |
Eriksson, P; Foth, M; Ismail, NFB; Iwata, T; Knowles, MA; Kung, JSC; Salmond, JM; Sansom, OJ; Sjödahl, G; Tomlinson, D | 1 |
Attalla, B; Bédard, A; Billger, M; Chang, J; Haile, S; Kirk, J; Söderberg, M | 1 |
Du, Z; Guo, H; Li, C; Wang, R; Xiong, W; Xue, J; Yu, M | 1 |
Chang, C; Chen, CC; Chuang, WM; Hsieh, TF; Hung, XF; Lin, MH; Ma, WL; Shyr, CR; Tsai, YR; Zhang, C; Zhang, Q | 1 |
DeGregorio, MW; Griffey, SM; Gutierrez, AM; Hanson, GK; Kao, CJ; Vang, DP; Wolf, M; Wurz, GT | 1 |
Beachy, PA; Honeycutt, JD; Hsieh, MH; Kawano, S; Lim, A; Odegaard, JI; Shin, K | 1 |
Huang, X; Xu, Q; Xu, Y; Yang, J; Zhang, G; Zhang, Z | 1 |
Dahm, HH; Lehnen-Holtum, V; Rübben, H | 1 |
Lee, JK; Theodorescu, D; Williams, PD | 1 |
Barbisan, LF; de Moura, NA; Grassi, TF; Rodrigues, MA | 1 |
Chyau, CC; Hsu, JD; Lee, HJ; Ou, TT; Wang, CJ; Wu, CH | 1 |
Cunha, FX; Figueiredo, A; Garrido, P; Mota, A; Neto, P; Nunes, S; Parada, B; Pinto, R; Reis, F; Rocha-Pereira, P; Rodrigues-Santos, P; Ruivo, J; Sereno, J; Teixeira, F; Teixeira-Lemos, E | 1 |
Fujii, N; Kobayashi, T; Kotani, H; Masutani, H; Matsui, Y; Nishiyama, H; Nishizawa, K; Ogawa, O; Oishi, S; Saito, R; Toda, Y; Yodoi, J | 1 |
Bae, SC; Kim, J; Kim, SK; Kim, WJ; Lee, OJ; Yun, SJ | 1 |
Izumi, K; Li, Y; Miyamoto, H | 1 |
Albuquerque, IL; Alves, MK; Castro, JD; de Almeida, PR; Dias, TA; Dornelas, CA; Faria, MH; Fechine-Jamacaru, FV; Lemos, TL; Magalhães, HI; Moraes, ME; Moraes, MO; Rabenhorst, SH | 1 |
Iseda, T; Takei, S; Yokoyama, M | 1 |
Matsushima, M; Sato, D | 1 |
Abdul-Ghani, R; Ariel, I; Ayesh, B; Ayesh, S; Birman, T; de Groot, N; Gofrit, O; Hochberg, A; Pizov, G; Schneider, T; Sidi, AA; Smith, Y | 1 |
Ayesh, S; Birman, T; Dinaburg, A; Gofrit, ON; Hochberg, A; Ohana, P | 1 |
Barbisan, LF; Bidinotto, LT; Rocha, NS; Salvadori, DM; Spinardi-Barbisan, AL | 1 |
Aota, Y; Kobayashi, O; Koshikawa, T; Mitsuta, H; Murase, T | 1 |
Becci, PJ; Brown, CC; Moon, RC; Sporn, MB; Strum, JM; Thompson, HJ | 1 |
Akagi, K; Hara, Y; Hirose, M; Hoshiya, T; Ito, N; Takahashi, S | 1 |
Akaza, H; Ami, Y; Ideyama, Y; Imada, S; Koiso, K; Takenaka, T | 1 |
Frolov, AG; Iogannsen, MG; Pliss, GB; Vlasov, NN | 1 |
Ariel, I; Ayesh, S; de Groot, N; Elkin, M; Hochberg, A; Schneider, T | 1 |
Sato, D | 1 |
Adamek, M; Gabius, HJ; Kunze, E; Schulz, H | 1 |
Grubbs, CJ; Hill, DL; Kelloff, GJ; Koki, AT; Leahy, KM; Lubet, RA; Masferrer, JL; Seibert, K; Steele, VE | 1 |
Fukushima, S; Hayashi, Y; Hosono, M; Makino, S; Mori, S; Murai, T; Ohara, T; Takeda, R; Takeuchi, Y | 1 |
Bach, PH | 1 |
Kobayashi, Y | 1 |
Babaya, K; Hirao, Y; Momose, H; Okajima, E; Ozono, S; Samma, S | 1 |
Fukushima, S | 1 |
Babaya, K; Hirao, Y; Okajima, E; Ozono, S; Sanma, S; Sasaki, K | 1 |
Chowaniec, J; Chrysostomou, E; Gwynne, J; Hicks, RM; Nandra, K; Pedrick, M; Tomlinson, CN; Turton, JA | 1 |
3 review(s) available for butylhydroxybutylnitrosamine and Disease Models, Animal
Article | Year |
---|---|
The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cell Transformation, Neoplastic; Disease Models, Animal; FANFT; Humans; Mice; Mice, Transgenic; Urinary Bladder Neoplasms | 2018 |
The role of the androgen receptor in the development and progression of bladder cancer.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Castration; Disease Models, Animal; Disease Progression; Evidence-Based Medicine; Female; Gene Expression Regulation, Neoplastic; Humans; Incidence; Male; Neoplasms, Hormone-Dependent; Receptors, Androgen; Risk Factors; Sex Factors; Signal Transduction; Urinary Bladder Neoplasms | 2012 |
A molecular basis for target-cell toxicity and upper urothelial carcinoma in analgesic abusers and patients with Balkan endemic nephropathy.
Topics: Analgesics; Animals; Balkan Nephropathy; Butylhydroxybutylnitrosamine; Carcinogenicity Tests; Carcinogens; Cocarcinogenesis; Disease Models, Animal; Epithelium; Europe; FANFT; Humans; Hyperplasia; Incidence; Kidney Neoplasms; Kidney Papillary Necrosis; Models, Biological; Mycotoxicosis; Ochratoxins; Precancerous Conditions; Rats; Rats, Inbred Strains; Rodentia; Smoking; Substance-Related Disorders; Ureteral Neoplasms | 1991 |
38 other study(ies) available for butylhydroxybutylnitrosamine and Disease Models, Animal
Article | Year |
---|---|
Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway.
Topics: Animals; Apoptosis; Butylhydroxybutylnitrosamine; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Luteolin; Male; Mice; Proto-Oncogene Proteins c-akt; Rats; rho GTP-Binding Proteins; Signal Transduction; Thioredoxins; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Alterations in detrusor contractility in rat model of bladder cancer.
Topics: Animals; Butylhydroxybutylnitrosamine; Disease Models, Animal; Male; Muscle Contraction; Rats; Rats, Wistar; TRPV Cation Channels; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Incontinence | 2020 |
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Longitudinal Studies; Male; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Proteinuria; Proteomics; Sequence Analysis, RNA; Single-Cell Analysis; Urinary Bladder; Urinary Bladder Calculi; Urothelium | 2021 |
FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation.
Topics: Animals; Butylhydroxybutylnitrosamine; Cell Transformation, Neoplastic; Cholecystitis, Acute; Disease Models, Animal; Disease Progression; Female; Genetic Predisposition to Disease; Lymphocytes; Male; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neutrophil Infiltration; Neutrophils; Phenotype; Receptor, Fibroblast Growth Factor, Type 3; Time Factors; Tumor Microenvironment; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2018 |
A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
Topics: Administration, Oral; Animals; Benzhydryl Compounds; Butylhydroxybutylnitrosamine; Disease Models, Animal; Dose-Response Relationship, Drug; Glucosides; Male; Rats; Rats, Sprague-Dawley; Urinary Bladder Neoplasms | 2019 |
[Long-term anti-cancer implants inhibiting the activity of tumor growth in animal models].
Topics: Animals; Antineoplastic Agents; Butylhydroxybutylnitrosamine; Delayed-Action Preparations; Disease Models, Animal; Doxorubicin; Female; Implants, Experimental; Polyanhydrides; Rats; Rats, Sprague-Dawley; Urinary Bladder Neoplasms | 2013 |
Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation.
Topics: Androgens; Animals; Butylhydroxybutylnitrosamine; Carcinogenesis; Castration; Disease Models, Animal; Disease Progression; Epidermal Growth Factor; ErbB Receptors; Humans; Male; Mice; Mitogen-Activated Protein Kinase Kinases; Phosphatidylinositol 3-Kinases; Quinazolines; Receptors, Androgen; Signal Transduction; Transcriptional Activation; Urinary Bladder Neoplasms | 2013 |
Induction of invasive transitional cell bladder carcinoma in immune intact human MUC1 transgenic mice: a model for immunotherapy development.
Topics: Animals; Butylhydroxybutylnitrosamine; Cancer Vaccines; Carcinogens; Carcinoma, Transitional Cell; Cytokines; Disease Models, Animal; Female; Humans; Immunotherapy; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mucin-1; T-Lymphocytes, Cytotoxic; Urinary Bladder Neoplasms | 2013 |
Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma; Cell Lineage; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Genotype; Hedgehog Proteins; Humans; Male; Mice; Mice, Transgenic; Neoplasm Invasiveness; Neoplastic Stem Cells; Phenotype; Recombinant Fusion Proteins; Time Factors; Tumor Burden; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2014 |
The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer.
Topics: Androgens; Animals; Apoptosis; Butylhydroxybutylnitrosamine; Cell Proliferation; Disease Models, Animal; Male; Mice; Orchiectomy; Receptors, Androgen; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms | 2015 |
[Karyometry of BBN-induced precancerosis of the urothelium : An experimental analysis].
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Disease Models, Animal; Karyometry; Precancerous Conditions; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Urinary Bladder Neoplasms; Urothelium | 2016 |
Molecular credentialing of rodent bladder carcinogenesis models.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Disease Models, Animal; Disease Progression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Invasiveness; Oligonucleotide Array Sequence Analysis; Rats; Urinary Bladder Neoplasms | 2008 |
Potential effects of the herbicide Diuron on mammary and urinary bladder two-stage carcinogenesis in a female Swiss mouse model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Butylhydroxybutylnitrosamine; Carcinogens; Disease Models, Animal; Diuron; Dose-Response Relationship, Drug; Female; Herbicides; Immunohistochemistry; Mammary Glands, Animal; Mice; Random Allocation; Urinary Bladder Neoplasms | 2010 |
Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Butylhydroxybutylnitrosamine; Carcinoma; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 2; Disease Models, Animal; Drugs, Chinese Herbal; Humans; Male; Paeonia; Phosphorylation; Phytotherapy; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Urinary Bladder Neoplasms; Urothelium | 2011 |
Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Inflammation Mediators; Kidney; Liver; Male; Oxidation-Reduction; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Urinary Bladder Neoplasms | 2010 |
Thioredoxin-interacting protein suppresses bladder carcinogenesis.
Topics: Aged; Animals; Blotting, Western; Butylhydroxybutylnitrosamine; Carrier Proteins; Chemokine CXCL12; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Staging; Prognosis; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Survival Rate; Thioredoxins; Urinary Bladder Neoplasms | 2011 |
Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model.
Topics: Animals; Butylhydroxybutylnitrosamine; Disease Models, Animal; Female; Gene Expression Profiling; Genes, myc; Humans; Mice; Niacinamide; Reproducibility of Results; Species Specificity; Urinary Bladder Neoplasms | 2011 |
Angiogenesis inhibition by green propolis and the angiogenic effect of L-lysine on bladder cancer in rats.
Topics: Angiogenesis Inhibitors; Animals; Butylhydroxybutylnitrosamine; Carcinoma; Disease Models, Animal; Female; Lysine; Neovascularization, Pathologic; Plant Extracts; Propolis; Rats; Rats, Wistar; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Water | 2012 |
Inhibitory effect of clotrimazole on angiogenesis associated with bladder epithelium proliferation in rats.
Topics: Animals; Base Sequence; Butylhydroxybutylnitrosamine; Cell Division; Clotrimazole; Disease Models, Animal; Endothelial Growth Factors; Epithelium; Female; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Lymphokines; Molecular Sequence Data; Neovascularization, Pathologic; Probability; Random Allocation; Rats; Rats, Wistar; Reference Values; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors | 2003 |
Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Camellia sinensis; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Phytotherapy; Plant Leaves; Plant Preparations; Rats; Rats, Wistar; Tea; Treatment Outcome; Urinary Bladder Neoplasms | 2003 |
Gene expression in the bladder carcinoma rat model.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Disease Models, Animal; DNA, Complementary; Gene Expression; Gene Expression Profiling; Insulin-Like Growth Factor II; Male; Rats; Rats, Wistar; RNA, Long Noncoding; RNA, Untranslated; Time Factors; Up-Regulation; Urinary Bladder Neoplasms | 2004 |
Chemically induced bladder cancer--a sonographic and morphologic description.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Disease Models, Animal; Female; Rats; Rats, Wistar; Ultrasonography; Urinary Bladder; Urinary Bladder Neoplasms | 2006 |
Effects of ginger (Zingiber officinale Roscoe) on DNA damage and development of urothelial tumors in a mouse bladder carcinogenesis model.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Disease Models, Animal; DNA Damage; Male; Methylnitrosourea; Mice; Neoplasm Invasiveness; Plant Extracts; Urinary Bladder Neoplasms; Urologic Neoplasms; Zingiber officinale | 2006 |
[Histological study of urinary bladder tumor: DNA of rat urinary bladder tumor caused by N-butyl-N-(4-hydroxybutyl) nitrosamine and that of human bladder tumor].
Topics: Animals; Butylhydroxybutylnitrosamine; Cell Transformation, Neoplastic; Disease Models, Animal; DNA, Neoplasm; Humans; Male; Nitrosamines; Papilloma; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1983 |
N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.
Topics: Animals; Butylhydroxybutylnitrosamine; Disease Models, Animal; Male; Mice; Microscopy, Electron; Neoplasms, Experimental; Nitrosamines; Tretinoin; Urinary Bladder Neoplasms | 1981 |
Effects of green tea catechins in a rat multi-organ carcinogenesis model.
Topics: 1,2-Dimethylhydrazine; Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Butylhydroxybutylnitrosamine; Carcinogenicity Tests; Catechin; Cocarcinogenesis; Colonic Neoplasms; Dimethylhydrazines; Disease Models, Animal; Intestinal Neoplasms; Intestine, Small; Kidney Neoplasms; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Models, Biological; Neoplasms, Experimental; Rats; Rats, Inbred F344 | 1993 |
Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats.
Topics: Administration, Oral; Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma; Cholestenone 5 alpha-Reductase; Disease Models, Animal; Enzyme Inhibitors; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Immunohistochemistry; Leuprolide; Male; Mice; Mice, Inbred C3H; Oxidoreductases; Rats; Rats, Wistar; Urinary Bladder Neoplasms | 1997 |
[A model of rat's urinary bladder tumor induced by subcutaneous injection of N-butyl-N-(4-hydroxybutyl)-nitrosamine].
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma in Situ; Carcinoma, Transitional Cell; Disease Models, Animal; Glucuronidase; Papilloma; Rats; Urinary Bladder Neoplasms | 1998 |
The dynamics of the imprinted H19 gene expression in the mouse model of bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cell Transformation, Neoplastic; Disease Models, Animal; Disease Progression; Epithelial Cells; Female; Gene Expression; Genomic Imprinting; In Situ Hybridization; Mice; Mice, Inbred C3H; Muscle Proteins; Precancerous Conditions; RNA, Long Noncoding; RNA, Untranslated; Urinary Bladder Neoplasms | 1998 |
Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea.
Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperplasia; Male; Papilloma; Rats; Rats, Wistar; Tea; Urinary Bladder Neoplasms | 1999 |
Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Disease Models, Animal; Drug Administration Schedule; Female; Galactosides; Immunity, Cellular; Immunohistochemistry; Incidence; Lectins; Mistletoe; Phytotherapy; Plant Lectins; Plant Preparations; Plant Proteins; Plants, Medicinal; Rats; Rats, Wistar; Ribosome Inactivating Proteins, Type 2; Specific Pathogen-Free Organisms; Toxins, Biological; Treatment Failure; Urinary Bladder Neoplasms | 2000 |
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organ Specificity; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred F344; Sulfonamides; Urinary Bladder Neoplasms | 2000 |
Renal pelvic carcinoma which shows metastatic potential to distant organs, induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
Topics: Abdominal Neoplasms; Animals; Body Weight; Butylhydroxybutylnitrosamine; Disease Models, Animal; Hydronephrosis; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Urinary Bladder Neoplasms | 1991 |
[Urinary bladder carcinogenicity of BBN in beige mice (Chediak-Higashi disease model)].
Topics: Animals; Butylhydroxybutylnitrosamine; Chediak-Higashi Syndrome; Disease Models, Animal; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Microscopy, Electron, Scanning; Nitrosamines; Urinary Bladder Neoplasms | 1989 |
[Experimental model of urinary bladder tumor in rats for evaluation of chemotherapeutic agents].
Topics: Animals; Antineoplastic Agents; Butylhydroxybutylnitrosamine; Disease Models, Animal; Drug Screening Assays, Antitumor; Male; Rats; Rats, Inbred F344; Rats, Inbred Strains; Urinary Bladder Neoplasms | 1988 |
[Animal models of bladder cancer].
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemical Phenomena; Chemistry; Disease Models, Animal; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Precancerous Conditions; Rats; Urinary Bladder Neoplasms | 1988 |
Scanning electron microscopy of changes in the urinary bladder in dogs treated with N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Disease Models, Animal; Dogs; Epithelium; Female; Hyperplasia; Nitrosamines; Urinary Bladder; Urinary Bladder Neoplasms | 1987 |
Modulation of carcinogenesis in the urinary bladder by retinoids.
Topics: Animals; Butylhydroxybutylnitrosamine; Cell Transformation, Neoplastic; Disease Models, Animal; Epithelium; Mice; Mice, Inbred Strains; Rats; Rats, Inbred F344; Retinoids; Time Factors; Urinary Bladder Neoplasms | 1985 |